Patients with melanoma and diabetes benefit from metformin treatment
Br J Dermatol
.
2023 Jan 23;188(1):e5.
doi: 10.1093/bjd/ljac150.
PMID:
36689538
DOI:
10.1093/bjd/ljac150
No abstract available
Publication types
Comment
MeSH terms
Diabetes Mellitus*
Diabetes Mellitus, Type 2*
Humans
Hypoglycemic Agents
Melanoma* / chemically induced
Metformin* / adverse effects
Substances
Metformin
Hypoglycemic Agents